Output Smoothing in EMU and OECD: Can We Forego Government Contribution? A risk sharing approach [PDF]
This paper analyses the smoothing of asymmetric shocks to output for a sample of OECD countries. The research finds no evidence of large differences in the patterns of risk sharing for the 19 OECD countries, the EU-15 or euro-area countries, for the ...
Carlos Marinheiro
core
Implementing performance-based risk-sharing agreements in non-small cell lung cancer immunotherapy: a real-world data case study. [PDF]
Health Econ RevBártová A +4 more
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Intergenerational Risk Sharing, Pensions and Endogenous Labor Supply in General Equilibrium [PDF]
In the context of a two-tier pension system, with a pay-as-you-go first tier and a fully funded second tier, we demonstrate that a system with a defined wage-indexed second tier performs strictly better than one with a defined contribution or defined ...
Roel Beetsma, Ward E. Romp, Siert J. Vos
core
A risk sharing model for old community renewal project based on bargaining game model. [PDF]
Sci RepHuo X, Xue H, Xu X, Hao T, Jiao L.
europepmc +1 more source
Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World? [PDF]
Clin Drug Investig, 2020 Kim AE, Choi DH, Chang J, Kim SH.
europepmc +1 more source
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Public Employment and Regional Risk Sharing: Norway 1977-90 [PDF]
We provide an empirical analysis of regional risk sharing in Norway over the period 1977-90. The approach of Asdrubali, Sørensen and Yosha (1996) is extended to take account of public employment as a possible shock absorber.
Lars-Erik Borge, Egil Matsen
core
A framework for ex-ante evaluation of the potential effects of risk equalization and risk sharing in health insurance markets with regulated competition. [PDF]
Health Econ Revvan Kleef RC +3 more
europepmc +1 more source